Finally, our observations also highlight the ability of at least three cytotoxic agents to induce apoptosis independently of BIM, and suggest that the success of modern day ALL regimens is due to the ability of individual agents to kill leukemia cells via targeting different components of the “BCL-2 rheostat”. This evidence concerns the gene BCL2 and leukemia.